Synthesis and biological evaluation of novel thienopyrimidine derivatives as diacylglycerol acyltransferase 1 (DGAT-1) inhibitors

被引：14

作者：

Hong, Dong Jin ^{[1
,2
]}

Jung, Seung Hyun ^{[2
]}

Kim, Jisook ^{[2
]}

Jung, Danbee ^{[1
]}

Ahn, Young Gil ^{[2
]}

Suh, Kwee Hyun ^{[2
]}

Min, Kyung Hoon ^{[1
]}

机构：

[1] Chung Ang Univ, Coll Pharm, Seoul, South Korea

[2] Hanmi Pharm Co Ltd, Hanmi Res Ctr, Hwaseong Si, Gyeonggi Do, South Korea

来源：

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 2020年 / 35卷 / 01期

关键词：

DGAT-1; obesity; small molecules; thienopyrimidine; type; 2; diabetes; OBESITY; DISCOVERY; POTENT; TRIGLYCERIDES; RESISTANCE; ESTERS;

D O I：

10.1080/14756366.2019.1693555

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A novel series of thieno[3,2-d]pyrimidine derivatives were synthesised and their inhibitory effects against diacylglycerol acyltransferase 1 (DGAT-1) were assessed. cis-Isomer 17a showed potent and selective inhibitory activity against DGAT-1 in SF9 cells. In addition, 17a had an acceptable pharmacokinetic profile and accumulated mainly in the small intestine and liver. Oral administration of 17a led to a significant reduction in plasma triacylglycerol level during an oral lipid tolerance test (OLTT) in murine and canine models. Taken together, 17a is a high-quality candidate that deserves further investigation.

引用

页码：227 / 234

页数：8

共 23 条

[1] [Anonymous], 2012, J CLIN LIPIDOL, DOI [10.1016/j.jacl.2012.04.034, DOI 10.1016/J.JACL.2012.04.034]
[2] Role of DGAT enzymes in triacylglycerol metabolism
Bhatt-Wessel, Bhumika
Jordan, T. William
Miller, John H.
Peng, Lifeng
[J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2018, 655 : 1 - 11
[3] Birch AM, 2010, CURR OPIN DRUG DISC, V13, P489
[4] Discovery of a Potent, Selective, and Orally Efficacious Pyrimidinooxazinyl Bicyclooctaneacetic Acid Diacylglycerol Acyltransferase-1 Inhibitor
Birch, Alan M.
Birtles, Susan
Buckett, Linda K.
Kemmitt, Paul D.
Smith, Graham J.
Smith, Tim J. D.
Turnbull, Andrew V.
Wang, Steven J. Y.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (06) : 1558 - 1568
[5] Insulin resistance and steatosis in humans
Capeau, J.
[J]. DIABETES & METABOLISM, 2008, 34 (06) : 649 - 657
[6] SYNTHESIS OF 3-SUBSTITUTED THIENO[2,3-D]PYRIMIDIN-4(3H)-ONE-2-MERCAPTOACETIC ACIDS AND THEIR ETHYL-ESTERS FOR PHARMACOLOGICAL SCREENING
DEVANI, MB
SHISHOO, CJ
PATHAK, US
PARIKH, SH
SHAH, GF
PADHYA, AC
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (05) : 660 - 664
[7] Dow RL, 2009, PREPARATION SUBSTITU
[8] Successful Strategies for Mitigation of a Preclinical Signal for Phototoxicity in a DGAT1 Inhibitor
Harrison, Tyler J.
Bauer, Daniel
Berdichevsky, Alina
Chen, Xin
Duvadie, Rohit
Hoogheem, Benjamin
Hatsis, Panos
Liu, Qian
Mao, Justin
Miduturu, Vasumathy
Rocheford, Erik
Zecri, Frederic
Zessis, Richard
Zheng, Rui
Zhu, Qingming
Streeper, Ryan
Patel, Sejal J.
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (08): : 1128 - +
[9] METABOLISM OF LIPIDES
KENNEDY, EP
[J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1957, 26 : 119 - 148
[10] Inhibitors of diacylglycerol acyltransferase: a review of 2008 patents
King, Andrew J.
Judd, Andrew S.
Souers, Andrew J.
[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (01) : 19 - 29

← 1 2 3 →